Newsroom | 11840 results

LEVALLOIS-PERRET, France--(BUSINESS WIRE)--Cardiawave, medtech pionnière du développement d’une thérapie par ultrasons non invasive (NIUT) pour la sténose aortique, a reçu le certificat CE pour Valvosoft®, la première alternative thérapeutique non invasive au monde, pour le traitement de la sténose aortique sévère symptomatique (sSAS), une maladie grave, dégénérative, en forte croissance en raison du vieillissement de la population, et pour laquelle de nombreux patients dans le monde restent sa...

LEVALLOIS-PERRET, France--(BUSINESS WIRE)--Cardiawave, a pioneering medtech company developing non-invasive ultrasound therapy (NIUT) for aortic stenosis, has received CE Certificate for Valvosoft®, the world’s first non-invasive therapeutic alternative to treat Severe Symptomatic Aortic Stenosis (sSAS), a serious, degenerative and fast-growing disease due to population aging, which remains without a solution for many patients around the world. “Innovating to address unmet patient needs is at t...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) will outline its patient-focused strategy and share financial guidance during its annual investor conference. Entering 2026 with momentum for sustainable differentiated growth, Edwards is uniquely positioned with leading therapies across its core structural heart innovations for patients with aortic stenosis (AS), mitral regurgitation (MR), tricuspid regurgitation (TR) and pulmonic diseases, and expanding into emerging opportuniti...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fiscal 2025 financial results on Thursday, December 11, 2025, before markets open. A conference call and webcast to discuss the financial results will be held on Thursday, December 11, 2025, at 8:30am ET. To view, listen to, and participate in the live webcast, please follow the link below: https://eve...

KARACHI, Pakistan & LOS ANGELES--(BUSINESS WIRE)--Pioneering health tech firm Boston Health AI [BHAI], behind the world’s first AI-powered physician’s assistant HAMI, has appointed Dr. Monica Jain as its new Chief Operating Officer. Based in the United States, Dr. Jain brings more than a decade of experience across clinical practice, health-tech strategy, biomedical engineering, human factors, and early-stage company building. Her appointment comes as BHAI accelerates global expansion and conti...

NAPLES, Fla.--(BUSINESS WIRE)--Expanded indications provide surgeons flexibility for better patient outcomes, reinforcing Catalyst’s role as a leader in next-gen shoulder solutions....

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present eight posters at the American Epilepsy Society (AES) Annual Meeting, taking place Dec. 5-9 in Atlanta. These presentations highlight real-world evidence from the CORE-VNS study, the largest prospective, multinational observational study of VNS Therapy™ for Drug-Resistant Epilepsy (DRE), and new health economics analyses. “At the heart of LivaNova’s purpose as a Comp...

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT, RBOT.WS) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced an update to full-year 2025 financial guidance. Vicarious Surgical now expects full-year 2025 cash burn of approximately $45 million, representing a $5 million improvement from its previous guidance of $50 million. The improved guidance reflects disciplined cost management initiativ...

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today announced that it is well along in the multi-step and time-consuming process that is required to call a Special Meeting of Shareholders (the “Special Meeting”) at STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) to remove three directors from the Company’s Board of Directors (the “Board”). Broadwood, which owns 30.2% of STAAR’s outstanding common stock, continues to oppose th...

BOSTON--(BUSINESS WIRE)--Swan EndoSurgical Appoints Veteran Robotics and MedTech Leader Erik Todd as Chief Executive Officer...